Combinations for Treatment-Resistant Depression
16.8 هزار بار بازدید -
2 سال پیش
-
Learn the essentials of psychopharmacology
Learn the essentials of psychopharmacology from Dr. Stephen Stahl! This clip from Stahl’s Essential Psychopharmacology, Video Edition covers potential treatment options for treatment-resistant depression. Learn more: https://nei.global/epvideos
Triple-action combo, such as SSRI/SNRI plus NDRI. Selective serotonin reuptake inhibitor (SSRI) plus a norepinephrine dopamine reuptake inhibitor (NDRI) leads to a single boost for serotonin (5HT), norepinephrine (NE), and dopamine (DA). Serotonin norepinephrine reuptake inhibitor (SNRI) plus a norepinephrine dopamine reuptake inhibitor (NDRI) leads to a single boost for serotonin (5HT), a double boost for norepinephrine (NE), and a single boost for dopamine (DA).
California rocket fuel: SNRI plus mirtazapine. Combining a serotonin norepinephrine reuptake inhibitor (SNRI) with mirtazapine is a combination that has a great degree of theoretical synergy: 5HT is quadruple-boosted (with reuptake blockade, alpha 2 antagonism, 5HT2A antagonism, and 5HT2C antagonism), NE is quadruple-boosted (with reuptake blockade, alpha 2 antagonism, 5HT2A antagonism, and 5HT2C antagonism), and there may even be a double boost of dopamine (with 5HT2A and 5HT2C antagonism).
About: In Stahl’s Essential Psychopharmacology: Video Edition, the newly published fifth edition of the landmark textbook comes to life as Dr. Stahl himself presents every chapter with fully animated illustrations. Learn more: https://nei.global/epvideos
Stay updated with email alerts: https://nei.global/updates
Copyright © Neuroscience Education Institute. All rights reserved.
Interested in more Psychopharmacology? Check out the NEI Master Psychopharmacology Program: https://nei.global/mpp
Follow us on Facebook: https://nei.global/facebook
Follow us on LinkedIn: https://nei.global/linkedin
Follow us on Twitter: https://nei.global/twitter
Listen to the NEI Podcast!
Spotify: https://nei.global/podcastspotify
Apple Podcast: https://nei.global/podcastapple
Podcast Website: https://nei.global/podcast
Triple-action combo, such as SSRI/SNRI plus NDRI. Selective serotonin reuptake inhibitor (SSRI) plus a norepinephrine dopamine reuptake inhibitor (NDRI) leads to a single boost for serotonin (5HT), norepinephrine (NE), and dopamine (DA). Serotonin norepinephrine reuptake inhibitor (SNRI) plus a norepinephrine dopamine reuptake inhibitor (NDRI) leads to a single boost for serotonin (5HT), a double boost for norepinephrine (NE), and a single boost for dopamine (DA).
California rocket fuel: SNRI plus mirtazapine. Combining a serotonin norepinephrine reuptake inhibitor (SNRI) with mirtazapine is a combination that has a great degree of theoretical synergy: 5HT is quadruple-boosted (with reuptake blockade, alpha 2 antagonism, 5HT2A antagonism, and 5HT2C antagonism), NE is quadruple-boosted (with reuptake blockade, alpha 2 antagonism, 5HT2A antagonism, and 5HT2C antagonism), and there may even be a double boost of dopamine (with 5HT2A and 5HT2C antagonism).
About: In Stahl’s Essential Psychopharmacology: Video Edition, the newly published fifth edition of the landmark textbook comes to life as Dr. Stahl himself presents every chapter with fully animated illustrations. Learn more: https://nei.global/epvideos
Stay updated with email alerts: https://nei.global/updates
Copyright © Neuroscience Education Institute. All rights reserved.
Interested in more Psychopharmacology? Check out the NEI Master Psychopharmacology Program: https://nei.global/mpp
Follow us on Facebook: https://nei.global/facebook
Follow us on LinkedIn: https://nei.global/linkedin
Follow us on Twitter: https://nei.global/twitter
Listen to the NEI Podcast!
Spotify: https://nei.global/podcastspotify
Apple Podcast: https://nei.global/podcastapple
Podcast Website: https://nei.global/podcast
2 سال پیش
در تاریخ 1400/12/24 منتشر شده
است.
16,838
بـار بازدید شده